This conference is designed to raise awareness, clarify misconceptions, promote understanding, and stimulate essential discussion about Long COVID, also known as post-acute sequelae of COVID-19. It targets a diverse group including healthcare professionals, investigators, policymakers, and community representatives, focusing on the disorder’s clinical manifestations, effective management strategies, plausible preventive and therapeutic options, and the major public health challenges it presents globally. This dialogue is set within the unique context of the ongoing COVID-19 pandemic, acknowledging significant regional differences in epidemiology, health system capacity, and access to testing, vaccines, and treatments.

Knowledge surrounding symptom-specific testing and diagnostic recommendations for Long COVID remains limited, highlighting a critical need for sustained medical education and regular guideline updates. The program will address these gaps, featuring state-of-the-art lectures, case presentations, and interactive sessions tailored to global healthcare settings. Ample time is reserved for debates and panel discussions to enhance knowledge exchange and reinforce the implementation of the latest clinical guidelines and recommendations, including research on the protective role of vaccination and the efficacy of antiviral and other treatment strategies.